m
Recent Posts
Connect with:
Sunday / November 22.
Homeminews (Page 1277)

Oxervate, a treatment for moderate or severe neurotrophic keratitis, has been approved for use in the European Union. Patients with neurotrophic keratitis, a rare

The Turnbull Government has invested AU$9.46 million in genetics research aimed at preventing glaucoma blindness, through personalised treatments. Minister for Aged Care and Minister

Ralph Anderl, founder of ic! berlin, has sold the majority of his shares in the company to Premium Equity Partners. According to the German

Blind Citizens Australia and Vision 2020 have called on the Australian Government to address identified barriers to services for people aged 65 and over

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.